Search research articles
Contact Us
Filters
Showing results (311-320 of 322) with videos related to
Page
of 33
Sort By:
Biochemistry
|
May 30, 1989
Proton nuclear magnetic resonance study of the molecular and electronic structure of the heme cavity in Aplysia cyanometmyoglobin
D H Peyton, G N La Mar, U Pande, et al.
British Journal of Haematology
|
September 6, 2000
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study
D Capelli, G Santini, C De Souza, et al.
Bone Marrow Transplantation
|
September 12, 2001
Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience
A Olivieri, D Capelli, M Montanari, et al.
Biochemistry
|
July 11, 1995
Interactions among residues CD3, E7, E10, and E11 in myoglobins: attempts to simulate the ligand-binding properties of Aplysia myoglobin
S J Smerdon, S Krzywda, A M Brzozowski, et al.
The Journal of Biological Chemistry
|
May 13, 1994
Structural factors governing azide and cyanide binding to mammalian metmyoglobins
A Brancaccio, F Cutruzzolá, C T Allocatelli, et al.
The British Journal of Dermatology
|
December 21, 2016
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study
F Sampogna, L Puig, P Spuls, et al.
The British Journal of Dermatology
|
October 1, 2018
Reversibility of alexithymia with effective treatment of moderate-to-severe psoriasis: longitudinal data from EPIDEPSO
F Sampogna, L Puig, P Spuls, et al.
Oncogene
|
October 6, 2005
TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts
M Brunori, N Mathieu, M Ricoul, et al.
The British Journal of Dermatology
|
October 15, 2013
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis
K Reich, L Puig, C Paul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 15, 2005
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG
A Olivieri, G Santini, C Patti, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 322) with videos related to
Sort By:
Page
of 33
Biochemistry
|
May 30, 1989
Proton nuclear magnetic resonance study of the molecular and electronic structure of the heme cavity in Aplysia cyanometmyoglobin
D H Peyton, G N La Mar, U Pande, et al.
British Journal of Haematology
|
September 6, 2000
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study
D Capelli, G Santini, C De Souza, et al.
Bone Marrow Transplantation
|
September 12, 2001
Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience
A Olivieri, D Capelli, M Montanari, et al.
Biochemistry
|
July 11, 1995
Interactions among residues CD3, E7, E10, and E11 in myoglobins: attempts to simulate the ligand-binding properties of Aplysia myoglobin
S J Smerdon, S Krzywda, A M Brzozowski, et al.
The Journal of Biological Chemistry
|
May 13, 1994
Structural factors governing azide and cyanide binding to mammalian metmyoglobins
A Brancaccio, F Cutruzzolá, C T Allocatelli, et al.
The British Journal of Dermatology
|
December 21, 2016
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study
F Sampogna, L Puig, P Spuls, et al.
The British Journal of Dermatology
|
October 1, 2018
Reversibility of alexithymia with effective treatment of moderate-to-severe psoriasis: longitudinal data from EPIDEPSO
F Sampogna, L Puig, P Spuls, et al.
Oncogene
|
October 6, 2005
TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts
M Brunori, N Mathieu, M Ricoul, et al.
The British Journal of Dermatology
|
October 15, 2013
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis
K Reich, L Puig, C Paul, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 15, 2005
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG
A Olivieri, G Santini, C Patti, et al.
Page
of 33